MicroRNA and Cancer. 2nd ed. 2018

Codi QR

MicroRNA and Cancer. 2nd ed. 2018

Guardat en:

Dades bibliogràfiques
Autor principal:	Wu, Wei
Format:	Llibre
Idioma:	English
Publicat:	Springer New York 2020
Matèries:	Biomedicine Cancer Research
Accés en línia:	http://doi.org/10.1007/978-1-4939-7435-1 https://scholar.dlu.edu.vn/thuvienso/handle/DLU123456789/97450
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Thư viện lưu trữ:	Thư viện Trường Đại học Đà Lạt

Ítems similars

Recent Trends in Cancer Biology: Spotlight on Signaling Cascades and microRNAs
per: Fayyaz, Sundas, et al.
Publicat: (2020)

Prostate Cancer. 1st ed. 2018
per: Culig, Zoran
Publicat: (2020)

Inflammation and Cancer. 1st ed. 2018
per: Jenkins, Brendan J.
Publicat: (2020)

Colorectal Cancer. 1st ed. 2018
per: Beaulieu, Jean-François
Publicat: (2020)

Proteases and Cancer. 1st ed. 2018
per: Cal, Santiago, et al.
Publicat: (2020)

Cancer Stem Cells. 1st ed. 2018
per: Papaccio, Gianpaolo, et al.
Publicat: (2020)

Cancer Systems Biology. 1st ed. 2018
per: Stechow, Louise von
Publicat: (2020)

Cancer Epigenetics for Precision Medicine . 1st ed. 2018
per: Dumitrescu, Ramona G., et al.
Publicat: (2020)

Energy Balance and Prostate Cancer. 1st ed. 2018
per: Platz, Elizabeth A., et al.
Publicat: (2020)

Early Phase Cancer Immunotherapy . 1st ed. 2018
per: Patel, Sandip Pravin, et al.
Publicat: (2020)

MicroRNA Protocols . 3rd ed. 2018
per: Ying, Shao-Yao
Publicat: (2020)

Bioactive Components, Diet and Medical Treatment in Cancer Prevention
per: Waly, Mostafa I., et al.
Publicat: (2020)

The Heterogeneity of Cancer Metabolism
per: Le, Anne
Publicat: (2020)

Resistance to Anti-Cancer Therapeutics Targeting Receptor Tyrosine Kinases and Downstream Pathways
per: Yarden, Yosef, et al.
Publicat: (2020)

Glioblastoma. 1st ed. 2018
per: Placantonakis, Dimitris G.
Publicat: (2020)

Molecular Determinants of Head and Neck Cancer
per: Burtness, Barbara, et al.
Publicat: (2020)

Urothelial Carcinoma. 1st ed. 2018
per: Schulz, Wolfgang A, et al.
Publicat: (2020)

Multiple Myeloma. 1st ed. 2018
per: Heuck, Christoph, et al.
Publicat: (2020)

The Retinoblastoma Protein. 1st ed. 2018
per: Santiago-Cardona, Pedro G.
Publicat: (2020)

Tumor Organoids. 1st ed. 2018
per: Soker, Shay, et al.
Publicat: (2020)

Esophageal Adenocarcinoma. 1st ed. 2018
per: Lam, Alfred K.
Publicat: (2020)

Alcohol and Cancer
per: Vasiliou, Vasilis, et al.
Publicat: (2020)

D-type Cyclins and Cancer. 1st ed. 2018
per: Hinds, Philip W., et al.
Publicat: (2020)

Obesity, Fatty Liver and Liver Cancer
per: Yu, Jun
Publicat: (2020)

Focus on Gynecologic Malignancies. 1st ed. 2018
per: Berger, Nathan A., et al.
Publicat: (2020)

Targeting the DNA Damage Response for Anti-Cancer Therapy
per: Pollard, John, et al.
Publicat: (2020)

Resistance to Ibritumomab in Lymphoma
per: Hosono, Makoto, et al.
Publicat: (2020)

Reviews of Physiology, Biochemistry and Pharmacology, Vol. 175
per: Nilius, Bernd, et al.
Publicat: (2020)

Bioinformatics in MicroRNA Research. 1st ed. 2017
per: Huang, Jingshan, et al.
Publicat: (2020)

Exosomes, Stem Cells and MicroRNA
per: Mettinger, Karl L., et al.
Publicat: (2020)

MicroRNA Detection and Pathological Functions
per: Zhang, Xueji, et al.
Publicat: (2015)

Biomedical Applications of Metals
per: Rai, Mahendra, et al.
Publicat: (2020)

Molecular and Therapeutic actions of Thymoquinone
per: Younus, Hina
Publicat: (2020)

Innovations for Next-Generation Antibody-Drug Conjugates
per: Damelin, Marc
Publicat: (2020)

Reviews of Physiology, Biochemistry and Pharmacology Vol. 174
per: Nilius, Bernd, et al.
Publicat: (2020)

Resistance of Targeted Therapies Excluding Antibodies for Lymphomas
per: Ferreri, Andrés J. M.
Publicat: (2020)

Role of Tyrosine Kinases in Gastrointestinal Malignancies
per: Nagaraju, Ganji Purnachandra
Publicat: (2020)

Current status of cancer research in Asia, the middle east and oter countries
per: Wada, Takeo
Publicat: (1987)

Psychoneuroimmunology. 2nd ed. 2018
per: Yan, Qing
Publicat: (2020)

MicroRNAs expression profile of gefitinib resistant non-small cell lung cancer HCC827 cells /
per: Duong Hong Quan.